Journal of Probiotics & Health is one of the renowned top access journals in probiotics and health. This journal is a top leading podium for gaining and exchanging knowledge about novel research done in the associated field.
The Microbiome is a heterogeneous system consisting of millions of microbes that share our body space, leading some to suggest it is a newly discovered organ. It has been shown that the interaction between the microbiome and its host play a major role in immune modulation, as well as in several metabolic functions. Colonization of the gut starts before birth, and is dependent on known factors such as mode of delivery, type of feeding and gestational age. Disequilibrium between the beneficial and pathogenic bacteria of the gut will lead to alteration in the defence barrier mechanisms and in immune functions, and is associated with a number of acute and chronic conditions, such as sepsis, NEC, inflammatory bowel disease (IBD), type 2 diabetes, allergy and obesity. Supplemental bacteria have been demonstrated to modulate a variety of disorders in children and adults, including: inflammatory bowel diseases; bowel cancer, ulcerative colitis; irritable bowel syndrome, obesity, cholesterol levels and diarrhea, secondary to oral antibiotics.
OMICS Group is one of the top open access publishers with 700+ peer-reviewed journals along with eminent scientists in its Editorial Board and expert reviewers to carry rigorous peer-review process. The peer review process is highly appreciated by researchers globally. Editorial Board Members and Reviewers actively participate in the review process within 21 days and ensure the quality of the manuscripts. In addition to open-access publishing, OMICS also provides E-books, Scholar Central and more than 80 International Scientific Conferences under its umbrella.
Last date updated on November, 2020